Solventum (NYSE:SOLV) reported Q3 CY2025 results, with revenue hitting $2.10 billion, flat year on year but surpassing analyst estimates by 1.3%. The company’s non-GAAP profit of $1.50 per share beat expectations by 4.7%. Management raised full-year Adjusted EPS guidance to $5.96, a 7.3% increase. Operating margin rose to 80.6%, up from 13.2% last year. However, free cash flow dipped to -$22 million. Solventum’s organic revenue grew by 2.7% year on year, outperforming analyst expectations. The company’s market capitalization stands at $11.74 billion. CEO Bryan Hanson expressed optimism about the company’s progress.

Solventum’s revenue growth has been tepid at 1.4% over the last two years, while organic revenue growth averaged 1.9% annually. Despite revenue beating estimates, analysts project a 5.7% decline in the next 12 months. The company’s operating margin has been consistently profitable at 21% over the last four years. In Q3, Solventum’s operating margin reached 80.6%, showing increased efficiency. However, free cash flow was negative at -$22 million, indicating potential capital needs.

While Solventum had a strong quarter, investors should assess the stock’s overall valuation and business qualities before buying. The company’s stock price rose 1.4% post-earnings. Consider the broader context before making investment decisions.

Read more at Yahoo Finance: Solventum’s (NYSE:SOLV) Q3: Beats On Revenue